Table 1.
Clinical data of 370 HCC patients
| Clinical parameters | Variable | Total (370) | Percentages (%) |
|---|---|---|---|
| Age | < 65 | 221 | 59.73% |
| ≥65 | 149 | 40.27% | |
| Gender | Female | 121 | 32.70% |
| Male | 249 | 67.30% | |
| Histological grade | G1 | 55 | 14.86% |
| G2 | 177 | 47.84% | |
| G3 | 120 | 32.43% | |
| G4 | 13 | 3.51% | |
| unknow | 5 | 1.35% | |
| Pathological stage | Stage I | 172 | 46.49% |
| Stage II | 84 | 22.70% | |
| Stage III | 85 | 22.97% | |
| Stage IV | 5 | 1.35% | |
| unknow | 24 | 6.49% | |
| TMN | |||
| T staging | T1 | 182 | 49.19% |
| T2 | 92 | 24.86% | |
| T3 | 80 | 21.62% | |
| T4 | 13 | 3.51% | |
| TX/unknow | 3 | 0.81% | |
| N staging | N0 | 252 | 68.11% |
| N1 | 4 | 1.08% | |
| NX/unknow | 114 | 30.81% | |
| M staging | M0 | 266 | 71.89% |
| M1 | 4 | 1.08% | |
| MX | 100 | 27.03% | |
| Survival status | Dead | 125 | 33.78% |
| Alive | 245 | 67.40% | |